| 1 |
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
Jennifer Mitchell et al. · Nature Medicine
Open access |
10 May 2021 |
1,000 |
| 2 |
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Peter Gasser, Dominique H. Holstein, Yvonne Anne Michel et al. · The Journal of Nervous and Mental Disease
Open access |
4 Mar 2014 |
764 |
| 3 |
The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study
Michael C. Mithoefer, Mark T. Wagner, Ann T. Mithoefer et al. · Journal of Psychopharmacology
Open access |
19 Jul 2010 |
681 |
| 4 |
Single-Dose Psilocybin Treatment for Major Depressive Disorder
Charles L. Raison et al. · JAMA
Open access |
31 Aug 2023 |
543 |
| 5 |
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial
Michael C. Mithoefer, Ann T. Mithoefer, Allison A. Feduccia et al. · The Lancet Psychiatry
|
May 2018 |
447 |
| 6 |
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial
Jennifer Mitchell et al. · Nature Medicine
Open access |
14 Sep 2023 |
438 |
| 7 |
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study
Michael C. Mithoefer, Mark T. Wagner, Ann T. Mithoefer et al. · Journal of Psychopharmacology
Open access |
20 Nov 2012 |
379 |
| 8 |
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
Gabrielle Agin-Liebes, Tara C. Malone, Matthew M. Yalch et al. · Journal of Psychopharmacology
|
9 Jan 2020 |
363 |
| 9 |
Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study
Alicia L. Danforth, Charles S. Grob, Christopher M. Struble et al. · Psychopharmacology
Open access |
8 Sep 2018 |
289 |
| 10 |
3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial
Marcela Ot’alora G., Jim Grigsby, Bruce Poulter et al. · Journal of Psychopharmacology
Open access |
29 Oct 2018 |
234 |
| 11 |
MDMA-Assisted Psychotherapy Using Low Doses in a Small Sample of Women with Chronic Posttraumatic Stress Disorder
José Carlos Bouso, Rick Doblin, Magı́ Farré et al. · Journal of Psychoactive Drugs
|
Sep 2008 |
209 |
| 12 |
Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline
Allison A. Feduccia, Lisa Jerome, Berra Yazar‐Klosinski et al. · Frontiers in Psychiatry
Open access |
12 Sep 2019 |
173 |
| 13 |
MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study
Philip E. Wolfson, Julane Andries, Allison A. Feduccia et al. · Scientific Reports
Open access |
24 Nov 2020 |
172 |
| 14 |
Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy
Mark T. Wagner, Michael C. Mithoefer, Ann T. Mithoefer et al. · Journal of Psychopharmacology
Open access |
21 Jun 2017 |
165 |
| 15 |
Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study
Geoff Noller, Chris Miles Frampton, Berra Yazar‐Klosinski · The American Journal of Drug and Alcohol Abuse
Open access |
12 Apr 2017 |
152 |
| 16 |
Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer
STEPHEN D. ROSS, Gabrielle Agin-Liebes, Sharon L. Lo et al. · ACS Pharmacology & Translational Science
Open access |
18 Mar 2021 |
139 |
| 17 |
How do psychedelics work?
Robin Lester Carhart-Harris · Current Opinion in Psychiatry
|
3 Nov 2018 |
139 |
| 18 |
The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial
Marcel O. Bonn‐Miller, Sue Sisley, Paula Riggs et al. · PLoS ONE
Open access |
17 Mar 2021 |
133 |
| 19 |
5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines
Lindsay P. Cameron, Seona D. Patel, Maxemiliano V. Vargas et al. · ACS Chemical Neuroscience
Open access |
11 Jan 2023 |
122 |
| 20 |
The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy
Harry R. Sumnall, Jon C. Cole, Lisa Jerome · Journal of Psychopharmacology
|
31 Aug 2006 |
118 |
| 21 |
Playing With Fear: A Field Study in Recreational Horror
Marc Malmdorf Andersen, Uffe Schjoedt, Henry C. W. Price et al. · Psychological Science
Open access |
2 Nov 2020 |
115 |
| 22 |
The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT)
Johannes T. Reckweg, Malin Vedøy Uthaug, Attila Szabó et al. · Journal of Neurochemistry
Open access |
12 Feb 2022 |
113 |
| 23 |
MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults
Alicia L. Danforth, Christopher M. Struble, Berra Yazar‐Klosinski et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Open access |
9 Apr 2015 |
110 |
| 24 |
Canalization and plasticity in psychopathology
Robin Lester Carhart-Harris, Shamil Chandaria, David Erritzøe et al. · Neuropharmacology
Open access |
27 Dec 2022 |
109 |
| 25 |
A Clinical Plan for MDMA (Ecstasy) in the Treatment of Posttraumatic Stress Disorder (PTSD): Partnering with the FDA
Rick Doblin · Journal of Psychoactive Drugs
|
Jun 2002 |
99 |
| 26 |
Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey
Sandeep Manel Nayak, Hillary Jackson, Nathan D. Sepeda et al. · Frontiers in Psychiatry
Open access |
19 Sep 2023 |
92 |
| 27 |
Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments
Kyle T. Greenway, Nicolas Garel, Lisa Jerome et al. · Expert Review of Clinical Pharmacology
|
Jun 2020 |
92 |
| 28 |
Laboratory models of post-traumatic stress disorder: The elusive bridge to translation
Joseph E. Dunsmoor, Josh M. Cisler, Gregory A. Fonzo et al. · Neuron
Open access |
23 Mar 2022 |
91 |
| 29 |
MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial
Candice M. Monson, Anne Catherine Wagner, Ann T. Mithoefer et al. · European Journal of Psychotraumatology
Open access |
7 Dec 2020 |
91 |
| 30 |
The Past and Future of Psychedelic Science: An Introduction to This Issue
Richard Doblin, Merete Bruun Christiansen, Lisa Jerome et al. · Journal of Psychoactive Drugs
Open access |
15 Mar 2019 |
89 |
| 31 |
The association of psychedelic use and opioid use disorders among illicit users in the United States
Vincent D. Pisano, Nathaniel P Putnam, Hannah M. Kramer et al. · Journal of Psychopharmacology
|
14 Feb 2017 |
87 |
| 32 |
MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD
Timothy D. Brewerton, Julie B. Wang, Adèle Lafrance et al. · Journal of Psychiatric Research
Open access |
5 Mar 2022 |
85 |
| 33 |
Potential Psychiatric Uses for MDMA
BB Yazar‐Klosinski, MC Mithoefer · Clinical Pharmacology & Therapeutics
Open access |
10 Nov 2016 |
81 |
| 34 |
Diversity, equity, and access in psychedelic medicine
Monnica T. Williams, Beatriz Caiuby Labate · Journal of Psychedelic Studies
Open access |
27 Dec 2019 |
80 |
| 35 |
A Single Belief-Changing Psychedelic Experience Is Associated With Increased Attribution of Consciousness to Living and Non-living Entities
Sandeep Manel Nayak, Roland R. Griffiths · Frontiers in Psychology
Open access |
28 Mar 2022 |
78 |
| 36 |
Progress and promise for the MDMA drug development program
Allison A. Feduccia, Julie A. Holland, Michael C. Mithoefer · Psychopharmacology
|
20 Nov 2017 |
78 |
| 37 |
Is ecstasy perceived to be safe? A critical survey
Alex Gamma, Lisa Jerome, Matthias E. Liechti et al. · Drug and Alcohol Dependence
|
5 Oct 2004 |
78 |
| 38 |
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic et al. · Current Neuropharmacology
Open access |
5 Jan 2024 |
77 |
| 39 |
Therapeutic mechanisms of psychedelics and entactogens
Boris Dov Heifets, David E. Olson · Neuropsychopharmacology
Open access |
24 Jul 2023 |
71 |
| 40 |
Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care
STEPHEN D. ROSS, Manish Agrawal, Roland R. Griffiths et al. · Neuropharmacology
Open access |
27 Jun 2022 |
71 |
| 41 |
Expectancy Effects in Psychedelic Trials
Balázs Szigeti, Boris Dov Heifets · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
|
20 Feb 2024 |
69 |
| 42 |
The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD
Christopher R. N. Nicholas, Julie B. Wang, Allison R. Coker et al. · Drug and Alcohol Dependence
Open access |
11 Feb 2022 |
68 |
| 43 |
Modeling gene × environment interactions in PTSD using human neurons reveals diagnosis-specific glucocorticoid-induced gene expression
Carina Seah et al. · Nature Neuroscience
Open access |
20 Oct 2022 |
65 |
| 44 |
Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey
Brian Scott Barnett, Yvan Beaussant, Franklin King et al. · Journal of Psychoactive Drugs
|
19 Aug 2021 |
65 |
| 45 |
3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats
Holly Sue Hake, Jazmyne K.P. Davis, River R. Wood et al. · Physiology & Behavior
Open access |
4 Dec 2018 |
65 |
| 46 |
History and Future of the Multidisciplinary Association for Psychedelic Studies (MAPS)
Amy Emerson, Linnae Ponté, Lisa Jerome et al. · Journal of Psychoactive Drugs
|
2014 |
65 |
| 47 |
How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change
Richard J. Zeifman, Anne Catherine Wagner, Candice M. Monson et al. · Journal of Affective Disorders
|
3 May 2023 |
62 |
| 48 |
Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial
Jordan Sloshower, Richard J. Zeifman, Jeffrey R. Guss et al. · Scientific Reports
Open access |
17 Apr 2024 |
61 |
| 49 |
Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities
David B. Yaden, Matthew W. Johnson, Roland R. Griffiths et al. · The International Journal of Neuropsychopharmacology
Open access |
10 May 2021 |
61 |
| 50 |
An Integrated theory of false insights and beliefs under psychedelics
Hugh T. McGovern, Hilary Jane Grimmer, Manoj K. Doss et al. · Communications Psychology
Open access |
Aug 2024 |
57 |